text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "x vivo 15"
Too many choices? Use the filter option on the left to narrow your product listing.
151-160 of 1004 results
    HUVEC – Human Umbilical Vein Endothelial Cells, Pooled, in EGM™-2, Prescreened for Angiogenesis
    Compare
    HUVEC – Human Umbilical Vein Endothelial Cells, Pooled, in EGM™-2, Prescreened for Angiogenesis
    Catalog #: C2519AS

    Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, cultured in EGMTM-2, pre-screened for Angiogenesis and containing ≥ 500,000 cells

    AMP
    SG Cell Line 4D-Nucleofector™ X Kit S
    Compare
    SG Cell Line 4D-Nucleofector™ X Kit S
    Catalog #: V4XC-3032
    For efficient transfection of difficult-to-transfect cell lines, e.g. Ba/F3, Raji, or THP-1, in the 4D-Nucleofector® X Unit (20 µL format).
    SA
    SG Cell Line 4D-Nucleofector™ X Kit L
    Compare
    SG Cell Line 4D-Nucleofector™ X Kit L
    Catalog #: V4XC-3012
    For efficient transfection of difficult-to-transfect cell lines, e.g. Ba/F3, Raji, or THP-1, in the 4D-NucleofectorTM X Unit (100 µL format).
    SA
    SG Cell Line 4D-Nucleofector™ X Kit L
    Compare
    SG Cell Line 4D-Nucleofector™ X Kit L
    Catalog #: V4XC-3024
    For efficient transfection of difficult-to-transfect cell lines, e.g. Ba/F3, Raji, or THP-1, in the 4D-NucleofectorTM X Unit (100 µL format).
    SA
    SE Cell Line 384-well Nucleofector™ Kit
    Compare
    SE Cell Line 384-well Nucleofector™ Kit
    Catalog #: V5SC-1002
    For high-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 384-well HT NucleofectorTM System.
    SA
    SE Cell Line 384-well Nucleofector™ Kit
    Compare
    SE Cell Line 384-well Nucleofector™ Kit
    Catalog #: V5SC-1010
    For high-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 384-well HT NucleofectorTM System.
    ST
    SE Cell Line 96-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    SE Cell Line 96-well Nucleofector® Kit
    Catalog #: V4SC-1096

    For medium-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 4D-Nucleofector® 96-well Unit

    SA
    SE Cell Line 96-well Nucleofector<sup class=reg>®</sup> Kit (960 RCT)
    Compare
    SE Cell Line 96-well Nucleofector® Kit (960 RCT)
    Catalog #: V4SC-1960

    For medium-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 4D-Nucleofector® 96-well Unit

    SA
    P3 Primary Cell 4D-Nucleofector<sup class=reg>®</sup> LV Kit XL (5 x 1 RCT)
    Compare
    P3 Primary Cell 4D-Nucleofector® LV Kit XL (5 x 1 RCT)
    Catalog #: V4LP-3520
    For larger scale transfection of primary cells, e.g. human T cells or CD34+ hematopoietic stem cells in the LV NucleocuvetteTM Cartridge format when working with the 4D-NucleofectorTM LV Unit
    SA
    BSMC – Human Bronchial Smooth Muscle Cells
    Compare
    BSMC – Human Bronchial Smooth Muscle Cells
    Catalog #: CC-2576

    Cryopreserved ampule of Bronchial Smooth Muscle Cells (BSMC) containing ≥ 500,000 cells 

    EA
1-10 of 1374 results
  • References - X-Vivo™
    Overview of relevant references
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content.
  • Formulation - Leibovitz Medium (L-15)
    Components present in L-15 (12-700).
  • Formulation - Leibovitz Modified Medium (L-15)
    Composition of L-15 (12-669)
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
  • Instructions for Use - TheraPEAK® T-VIVO® Cell Culture Medium
    Instructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
  • Serum-free Media FFM Part Codes
    2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)